Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$506M |
| 2 |
Microsoft
MSFT
|
+$336M |
| 3 |
Amazon
AMZN
|
+$287M |
| 4 |
Apple
AAPL
|
+$269M |
| 5 |
Meta Platforms (Facebook)
META
|
+$233M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$425M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$334M |
| 3 |
United Parcel Service
UPS
|
+$148M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.28% |
| 2 | Financials | 7.45% |
| 3 | Healthcare | 7.23% |
| 4 | Industrials | 6.23% |
| 5 | Consumer Discretionary | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
PUT
Verizon
VZ
$194B
| $157K | ﹤0.01% |
3,800
| – | – |
|
|
EB
4502
DELISTED
Eventbrite
EB
| $157K | ﹤0.01% |
32,361
+4,321
| +15% | +$22.5K |
|
4503
CryoPort
CYRX
$741M
| $156K | ﹤0.01% |
22,614
+692
| +3% | +$9.32K |
|
4504
Taysha Gene Therapies
TSHA
$1.87B
| $156K | ﹤0.01% |
69,742
+62,334
| +841% | +$181K |
|
4505
Hippo Holdings
HIPO
$852M
| $156K | ﹤0.01% |
9,068
+4,862
| +116% | +$92.2K |
|
4506
Xometry
XMTR
$5.25B
| $156K | ﹤0.01% |
13,481
+1,615
| +14% | +$25.4K |
|
4507
Fulcrum Therapeutics
FULC
$291M
| $156K | ﹤0.01% |
25,120
+24,733
| +6,391% | +$187K |
|
4508
The RMR Group
RMR
$329M
| $156K | ﹤0.01% |
6,883
+1,829
| +36% | +$42.8K |
|
4509
Designer Brands
DBI
$335M
| $155K | ﹤0.01% |
22,766
+2,664
| +13% | +$23.6K |
|
4510
Entrada Therapeutics
TRDA
$280M
| $155K | ﹤0.01% |
10,899
+3,302
| +43% | +$46.9K |
|
|
JHS
4511
John Hancock Income Securities Trust
JHS
$128M
| $155K | ﹤0.01% |
14,223
-1,600
| -10% | -$17.7K |
|
4512
RCI Hospitality Holdings
RICK
$205M
| $155K | ﹤0.01% |
3,559
+675
| +23% | +$32.7K |
|
4513
SGHC Ltd
SGHC
$6.59B
| $155K | ﹤0.01% |
47,976
+8,226
| +21% | +$27.7K |
|
|
ALX
4514
Alexander's
ALX
$1.36B
| $155K | ﹤0.01% |
689
-17
| -2% | -$3.66K |
|
4515
Anika Therapeutics
ANIK
$281M
| $155K | ﹤0.01% |
6,107
+931
| +18% | +$24.1K |
|
4516
Stoke Therapeutics
STOK
$2.09B
| $154K | ﹤0.01% |
11,387
+1,535
| +16% | +$20.7K |
|
4517
Lindblad Expeditions
LIND
$2.17B
| $153K | ﹤0.01% |
15,841
+1,756
| +12% | +$13.6K |
|
4518
Liquidity Services
LQDT
$1.28B
| $153K | ﹤0.01% |
7,649
-459
| -6% | -$8.59K |
|
4519
Bally's
BALY
$647M
| $152K | ﹤0.01% |
12,722
+949
| +8% | +$12.1K |
|
4520
Huazhu Hotels Group
HTHT
$13.1B
| $152K | ﹤0.01% |
4,558
+272
| +6% | +$10.3K |
|
4521
Arbe Robotics
ARBE
$89.3M
| $151K | ﹤0.01% |
79,256
-4,478
| -5% | -$8.25K |
|
4522
Roundhill Sports Betting & iGaming ETF
BETZ
$49.8M
| $151K | ﹤0.01% |
8,866
+130
| +1% | +$2.23K |
|
|
SLRN
4523
DELISTED
ACELYRIN
SLRN
| $151K | ﹤0.01% |
34,243
-3,591
| -9% | -$16.8K |
|
4524
AngloGold Ashanti
AU
$48.4B
| $151K | ﹤0.01% |
6,007
+1,501
| +33% | +$35.6K |
|
4525
Ribbon Communications
RBBN
$368M
| $151K | ﹤0.01% |
45,846
-120
| -0.3% | -$365 |
|
Similar funds
Wells Fargo's Q2 2024 Portfolio in Review
As of Q2 2024, Wells Fargo held 7,784 positions worth $412B, down 0.64% from $415B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wells Fargo's Q2 2024 filing shows 386 new, 3,308 increased, 2,367 reduced and 944 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 1,487,927 shares worth $73.6M. The largest sale was Air Products & Chemicals, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 1,487,927 shares worth $73.6M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $506M increase.
- Wells Fargo's biggest Q2 2024 reduction was Air Products & Chemicals, cutting an estimated $425M.
- Wells Fargo fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $88.9M.
- Wells Fargo's ten largest holdings make up 19% of its $412B portfolio in Q2 2024.
- Wells Fargo opened 386 new positions and closed 944 in Q2 2024.
- Wells Fargo's portfolio value fell 0.64% quarter-over-quarter to $412B.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.